Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arthur Young was a prominent global accounting and professional services firm that played a foundational role in the development of the modern life sciences and biotechnology industries. Historically known as one of the "Big Eight" accounting firms, it was a pioneer in providing specialized financial, auditing, and strategic consulting services to early-stage biotech companies such as Genentech and Amgen. The firm was particularly noted for its influential annual "Arthur Young Biotech Report," which served as the industry's definitive analysis during the 1980s. In 1989, Arthur Young merged with Ernst & Whinney to form Ernst & Young (now EY), which continues to maintain a leading global practice in the healthcare and life sciences sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arthur Young.